Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Bertilimumab in Asthma

<< Previous

Bullboard Posts

Next >>

Comment by regardlesson Dec 17, 2020 3:52pm

95 Views

Post# 32130503

RE:RE:RE:RE:RE:RE:Bertilimumab in Asthma

Because this is a pump and dump trash stock
hoes up a few times a year but mostly stays in the two cents range to 4 cents

big volume is a chance for traders to liquidate shares easily

this needs a major catalyst to move it and it looks like we aren't getting one hence the low volume

im
just glad I only have 10$k in this stock
if it runs up then great ... if it doesn't than im
not mad

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism